Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | STS | P08842 | 4/20 | 0.44 |
| ▸ | RXRA | P19793 | 1/20 | 0.43 |
| ▸ | RXRB | P28702 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL9821317 | 0.98 | SMN1; SMN2 (0.50) | SMN1; SMN2CYP2C19CA2STSRXRA | |
| Ethylene Glycol SCHEMBL27465849 | 0.94 | SMN1; SMN2 (0.43) | SMN1; SMN2CYP2C19CA2STSRXRA | |
| Pyridine SCHEMBL15510549 | 0.87 | KMT2A (0.41) | SMN1; SMN2CYP2C19RXRARXRBRAB9A | |
| Benzoic Acid SCHEMBL15670791 | 0.85 | ALDH1A1 (0.56) | STSRXRARXRBALDH1A1RAB9A | |
| SCHEMBL7724408 | 0.84 | THRB (0.50) | CA2STSGLAGAAALDH1A1 | |
| SCHEMBL236311 | 0.83 | CA2 (0.48) | SMN1; SMN2CYP2C19CA2STSRXRA | |
| SCHEMBL7910581 | 0.82 | GLA (0.53) | CA2STSGLAGAA | |
| SCHEMBL14015390 | 0.81 | CA2 (0.51) | SMN1; SMN2CA2STSALDH1A1HPGD | |
| SCHEMBL21349987 | 0.81 | KDM4E (0.50) | SMN1; SMN2CYP2C19CA2STSRXRA | |
| SCHEMBL14431584 | 0.81 | CA2 (0.47) | CA2STSGLAGAAPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 415 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4022088-B1 | COMPOSITIONS COMPRISING TOMATO POMACE FOR USE IN METHODS OF TREATING AND REDUCING RISK OF CONDITIONS ASSOCIATED WITH ELEVATED 4-ETHYLPHENYL SULFATE IN CANINES AND METHODS OF IDENTIFYING CANINES AT RISK OF SUCH CONDITIONS | HILLS PET NUTRITION INC (US) | 2025-09-17 | — | — | EP | claimed |
| CN-113009122-B | Methods and systems for determining the risk of autism spectrum disorder | 美国控股实验室公司 | 2025-01-17 | — | — | CN | claimed |
| WO-2024257872-A1 | METHOD FOR PREDICTING GENE TRANSFER RATE | 武田薬品工業株式会社 | 2024-12-19 | — | — | WO | claimed |
| WO-2024243289-A2 | GUT MICROBE DERIVED AROMATIC AMINO ACID METABOLITES FOR DETECTION AND TREATMENT OF DISEASE | THE CLEVELAND CLINIC FOUNDATION (US) | 2024-11-28 | — | — | WO | claimed |
| EP-4424365-A2 | PET FOOD COMPOSITIONS | Hill's Pet Nutrition, Inc. (US) | 2024-09-04 | — | — | EP | claimed |
| EP-4017281-B1 | PET FOOD COMPOSITIONS | HILLS PET NUTRITION INC (US) | 2024-08-28 | — | — | EP | claimed |
| US-20240230622-A9 | Methods and Systems for Determining Autism Spectrum Disorder Risk | LABORATORY CORPORATION OF AMERICA HOLDINGS (US) | 2024-07-11 | — | — | US | claimed |
| CN-118252856-A | Application of the above bacteria belonging to Bacteroides | 表飞鸣制药株式会社 | 2024-06-28 | — | — | CN | claimed |
| US-20240133865-A1 | Methods and Systems for Determining Autism Spectrum Disorder Risk | LABORATORY CORPORATION OF AMERICA HOLDINGS (US) | 2024-04-25 | — | — | US | claimed |
| US-20240118291-A1 | DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDERS USING ALTERED RATIOS OF METABOLIC CONCENTRATIONS | STEMINA BIOMARKER DISCOVERY INC (US) | 2024-04-11 | — | — | US | claimed |
| EP-2797979-B1 | LOW TEMPERATURE CURABLE EPOXY SYSTEM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-11-04 | — | — | EP | claimed |
| US-9176113-B1 | Methods and systems for determining autism spectrum disorder risk | SYNAPDX CORPORATION (US) | 2015-11-03 | — | — | US | claimed |
| US-20150293072-A1 | METHODS AND SYSTEMS FOR DETERMINING AUTISM SPECTRUM DISORDER RISK | LABORATORY CORPORATION OF AMERICA HOLDINGS | 2015-10-15 | — | — | US | claimed |
| WO-2015157601-A1 | METHODS AND SYSTEMS FOR DETERMINING AUTISM SPECTRUM DISORDER RISK | SYNAPDX CORPORATION (US) | 2015-10-15 | — | — | WO | claimed |
| US-20150294081-A1 | METHODS AND SYSTEMS FOR DETERMINING AUTISM SPECTRUM DISORDER RISK | LABORATORY CORPORATION OF AMERICA HOLDINGS | 2015-10-15 | — | — | US | claimed |
| WO-2015157407-A1 | SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT | METABOLON, INC. (US) | 2015-10-15 | — | — | WO | claimed |
| EP-2890808-A2 | DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDER | California Institute of Technology (US) | 2015-07-08 | — | — | EP | claimed |
| US-20140065132-A1 | DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDER | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2014-03-06 | — | — | US | claimed |
| WO-2014036182-A2 | DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDER | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2014-03-06 | — | — | WO | claimed |
| US-8658351-B2 | Determining liver toxicity of an agent using metabolite biomarkers | METABOLON, INC. (US) | 2014-02-25 | — | — | US | claimed |